|
Author Question: How many sessions should clinicians usually allow for the process of terminating treatment? (a) ... (Read 15 times) |
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.
The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.
For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.
Medication errors are more common among seriously ill patients than with those with minor conditions.